Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Auricula Biosciences Inc.

United States 200 Continental Drive Suite 401, 19713-4337, United States

About the sponsor

Auricula Biosciences Inc. funds clinical research in advanced solid tumours, with a specific focus on KRAS-mutant cancers. Its trial activity is centred on treatment settings where tumour progression and resistance mechanisms remain major clinical challenges.

  • Advanced KRAS-mutant solid tumours
  • Antitumour activity
  • Monotherapy

The sponsor’s research portfolio is directed toward cancer therapeutics that target genetically defined malignancies across solid tumour types.

About Specializations

Auricula Biosciences Inc. runs clinical trials in conditions such as Neoplasm malignant, Neoplasm, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Neoplasm malignant+1

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:WEF-001
  • Sponsor:Auricula Biosciences Inc.

Neoplasm malignant+1

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:WEF-001
  • Sponsor:Auricula Biosciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.